
Sanofi Ventures
Description
Sanofi Ventures operates as the dedicated corporate venture capital arm of Sanofi, a leading global healthcare company. Established to identify and invest in innovative life science companies, the firm strategically aligns its investments with Sanofi's core therapeutic areas and emerging healthcare needs. Its primary mission is to foster groundbreaking scientific advancements and technological solutions that have the potential to transform patient care and contribute to Sanofi's long-term growth objectives. Sanofi Ventures leverages Sanofi's extensive R&D capabilities, global network, and deep industry expertise to provide portfolio companies with more than just capital, offering strategic guidance and operational support.
The firm primarily targets early to growth-stage companies, typically participating in Series A, B, and C rounds. Their investment focus spans a broad spectrum of life science innovations, including novel therapeutics, digital health solutions, medical devices, and other healthcare technologies. Sanofi Ventures seeks companies that are developing disruptive technologies or platforms with strong scientific foundations and clear pathways to clinical and commercial success. They often co-invest with other prominent venture capital firms, demonstrating a collaborative approach to funding promising ventures within the highly competitive biotech and healthcare sectors.
Sanofi Ventures manages a substantial pool of capital, with over $500 million in assets under management, enabling significant investments across its portfolio. This financial capacity allows them to support companies through multiple funding rounds as they progress through development milestones. Their portfolio comprises over 50 companies, reflecting a diversified investment strategy across various disease areas and technological modalities. The firm's commitment extends beyond initial funding, as they actively work to build long-term partnerships, aiming to accelerate the development and commercialization of innovative solutions that address critical unmet medical needs globally.
Investor Profile
Sanofi Ventures has backed more than 96 startups, with 14 new investments in the last 12 months alone. The firm has led 24 rounds, about 25% of its total and boasts 22 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series A, Series C rounds (top funding stages).
- Majority of deals are located in United States, Denmark, United Kingdom.
- Strong thematic focus on Biotechnology, Health Care, Medical.
- Led 5 rounds in the past year.
- Typical check size: $5M – $15M.
Stage Focus
- Series B (43%)
- Series A (26%)
- Series C (16%)
- Seed (6%)
- Series Unknown (4%)
- Post Ipo Equity (2%)
- Series D (2%)
- Series E (1%)
Country Focus
- United States (84%)
- Denmark (4%)
- United Kingdom (3%)
- France (2%)
- Australia (2%)
- Israel (1%)
- The Netherlands (1%)
- Switzerland (1%)
- Spain (1%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Therapeutics
- Pharmaceutical
- Life Science
- Biopharma
- Wellness
- Medical Device
- Genetics
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.